Kimal, an international manufacturer of medical equipment, has ramped up the production of its specialised procedure packs and devices, to support the fight against COVID-19 in the UK.
Founded in 1964, Kimal is an innovative manufacturer of customised procedure packs and vascular access devices to clinical departments in over 70 countries worldwide. The Company manufactures over 2 million procedure packs and vascular access devices every year for a range of specialities including: cardiology, radiology, pacing, laparoscopy, and cardiac surgery; and its unique, ground-breaking central venous catheter technology is helping to reduce patient risk in hospitals across the world.
At the start of the COVID-19 pandemic, Kimal made the decision to commit 100% of its UK manufacturing facility and a significant proportion of its international facility into producing equipment for the NHS. It created its specially designed Nightingale procedure pack through a dedicated multi-disciplinary team, and saw the first 1,000 manufactured, sterilised and despatched to the field hospital at the London ExCel on the 24th March. Production has since increased, with 14,000 packs being manufactured every week to support both UK and international efforts in the fight against COVID-19.
Alan Press, Executive Chairman of Kimal, said: “Whilst our packs are used in hospitals around the world, it felt morally right to pivot our efforts to help in the fight that’s right on our doorstep, here in the UK.”
“From manufacturing to logistics, our team has worked tirelessly to meet the urgent needs of the NHS, all whilst complying with social distancing. Whilst ensuring we maintain sufficient capacity to meet NHS needs, we are also now making our COVID-19 specialist packs available for our international distribution partners to help in their fight against this pandemic.”
In addition to the Kimal Nightingale procedure pack, the Company made the decision to commit 3 months manufacturing capacity of its central venous catheters to the NHS; for use in Critical Care to treat seriously ill COVID-19 patients.
The Kimal Home Patients team has also been working hard to help ICU teams in the UK overcome the shortage of much-needed dialysis machines and consumables; ensuring that patients who perform dialysis at home can continue to do so. Over recent weeks, the team has also been working with ICU departments in hospitals to supply essential consumables, ensuring uninterrupted dialysis for seriously ill patients.
Mark Pettitt, CEO of the Kimal Group, said: “I am so proud of our teams and what they have achieved at this difficult time. It is at times like this that we realise even more the importance of what we do, and I know that the staff here are incredibly proud of how they have contributed to the fight against COVID-19.”